| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | 0.09 | 0.02 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.02 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | 0.091 | 0.02 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.02 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | 0.089 | 0.02 |
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.02 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.073 | 0.02 |
| mRNA | UNC0638 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.02 |